Katie De Wagter

Katie De Wagter is with Johnson & Johnson Pharmaceutical Research & Development, 2340 Beerse, Belgium.

Articles by Katie De Wagter

Measurement of Metabolic Stability Using SIM and Identification of Metabolites by Data-Dependent full-Scan MS-MS and CNL Scanning

ByClaire Mackie,Dipankar Ghosh,Karel Lazou,Katie De Wagter,Ann Van Vlaslaer,Ron A.H.J. Gilissen,Peter B. Ehmer,Ethisjulu Kantharaj

May 1st 2006

Special Issues

In this article, the role of a triple-quadrupole mass spectrometer in performing in vitro studies of compound metabolic stability and identification of Phase I and II metabolites is demonstrated.

Latest Updated Articles

Measurement of Metabolic Stability Using SIM and Identification of Metabolites by Data-Dependent full-Scan MS-MS and CNL Scanning
May 1st 2006

Katie De Wagter

Articles by Katie De Wagter

Measurement of Metabolic Stability Using SIM and Identification of Metabolites by Data-Dependent full-Scan MS-MS and CNL Scanning

Latest Updated Articles

Trending on Spectroscopy Online

The International Atomic Spectrometry Association Selects 2028 Conference Location

New Method Pairs Terahertz Spectroscopy With AI to Authenticate Premium Ginseng's Age

Integrating New Digital Microfluidics Platforms in Real-World Clinical Settings

Lithium-Ion Battery Analysis: Four Years of Spectroscopic Advances in Research, Manufacturing, and Quality Assessment

Spectroscopy Top 10 Articles of the Month (May 2026)